Drug:
Reaction: PARAESTHESIA
20250101 - 20251231
No. 5001 - 5004
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 5001 | 24797003 |
CN |
31 | 1 |
Hypersensitivity, Blood pressure decreased, Heart rate decreased, Peripheral coldness, Erythema, Vomiting, Pruritus, Loss of consciousness, Syncope, Vertigo, Paraesthesia, Lip swelling, Mouth swelling, Pruritus, |
||||
LETIBOTULINUMTOXINA-WLBG, |
||||
| 5002 | 24797132 |
CA |
40 | 2 |
Peripheral venous disease, Pneumonia, Abdominal discomfort, Peripheral swelling, Pericarditis, Pemphigus, Pain in extremity, Pain, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Abdominal distension, Abdominal pain upper, Adverse reaction, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Paraesthesia, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Mobility decreased, Migraine, Memory impairment, Malaise, Grip strength decreased, |
||||
DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, CANDESARTAN, SECUKINUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, OXYCODONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RAMIPRIL, RAMIPRIL, RAMIPRIL, CALCIUM CARBONATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, NICOTINAMIDE, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE, ATOMOXETINE, ATOMOXETINE, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
| 5003 | 24797217 |
US |
52 | 2 |
Paraesthesia, |
||||
PALBOCICLIB, LETROZOLE, LETROZOLE TABLETS, GABAPENTIN, |
||||
| 5004 | 24797288 |
CA |
44 | 2 |
Breast cancer stage III, Intentional product misuse, Exostosis, Folliculitis, Muscular weakness, Bursitis, Lupus vulgaris, Red blood cell sedimentation rate increased, Product use issue, Peripheral swelling, Laryngitis, Anxiety, Abdominal pain upper, C-reactive protein abnormal, Glossodynia, Maternal exposure during pregnancy, Therapeutic product effect decreased, Bone erosion, C-reactive protein increased, Paraesthesia, Lupus-like syndrome, Gait disturbance, Adjustment disorder with depressed mood, Crohn^s disease, Hypercholesterolaemia, Treatment failure, Live birth, Dry mouth, Type 2 diabetes mellitus, Musculoskeletal pain, Sinusitis, Joint stiffness, Osteoarthritis, Nasopharyngitis, Peripheral venous disease, Wound, Respiratory tract infection, Prescribed overdose, Infection, Liver injury, Adverse event, Impaired healing, Normal newborn, Hepatic cirrhosis, Lower respiratory tract infection, Oedema, Pemphigus, Hand deformity, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, LISINOPRIL, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LISINOPRIL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, RITUXIMAB, RITUXIMAB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, GOLIMUMAB, QUETIAPINE FUMARATE, QUETIAPINE, OXYCODONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ADALIMUMAB, PHENYLEPHRINE HYDROCHLORIDE, TRIMETHOPRIM, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, CAFFEINE CITRATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SULFASALAZINE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, TOCILIZUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ALENDRONATE SODIUM, ALENDRONATE SODIUM, USTEKINUMAB, ETANERCEPT, ETANERCEPT, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ERGOCALCIFEROL, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ALENDRONATE SODIUM, ALENDRONATE SODIUM, CERTOLIZUMAB PEGOL, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, LANSOPRAZOLE, LORAZEPAM, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ACETAMINOPHEN,CAFFEINE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30
